Immix Biopharma Inc (IMMX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.49
• Market Cap: $449.59M
• EPS: $-0.77
• 52-Week High: $8.97
• 52-Week Low: $1.34

Market Sentiment

Immix Biopharma Inc currently has a Neutral sentiment score of 0.04.

About Immix Biopharma Inc

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Los Angeles, California, dedicated to developing innovative tissue-specific therapies targeting oncology and inflammatory diseases. The company is advancing a strong pipeline of drug candidates aimed at fulfilling significant unmet medical needs in both the United States and Australia. Through its commitment to cutting-edge research and strategic collaborations, Immix is establishing itself as a key player in...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Immix Biopharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMMX pay dividends?

Immix Biopharma Inc (IMMX) does not currently pay a regular dividend.

What is IMMX's market cap?

Immix Biopharma Inc (IMMX) has a market capitalization of $449.59M with a current stock price of $8.49.